Modi Naturals appoints A.K. Verma & Co. as Secretarial Auditor for five years

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Modi Naturals Limited has appointed M/s. A.K. Verma & Co. as its Secretarial Auditor for a five-year term starting FY 2026-27, following their approval at the 52nd AGM. The appointment replaces M/s. Deepak Bansal & Associates and aligns with SEBI LODR regulations.

powered bylight_fuzz_icon
47114945

*this image is generated using AI for illustrative purposes only.

Shareholders of Modi Naturals Limited have appointed M/s. A.K. Verma & Co. as the company's Secretarial Auditor for a term of five consecutive financial years, from FY 2026-27 to FY 2030-31. The resolution was passed unanimously at the company's 52nd Annual General Meeting (AGM) held on July 31, 2026, replacing the outgoing firm M/s. Deepak Bansal & Associates, who resigned from the position. This appointment ensures continuity in corporate governance compliance for the next cycle of audits.

The appointment was made pursuant to Regulation 30 read with sub-para 7 of Para A Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The term is effective from the conclusion of the 52nd AGM and will remain valid until the conclusion of the 57th AGM. The firm, based in Delhi, holds Firm Registration No. P1997DE091500 and is led by Mr. Ashok Kumar Verma, who serves as the designated auditor.

Appointment Details

The new Secretarial Auditor brings extensive experience in corporate laws, secretarial audit, and regulatory compliances. The firm has served a diverse clientele including listed companies, multinational corporations, and public sector undertakings. Mr. Ashok Kumar Verma holds Council Registration No. FCS 3945 and Certificate of Practice No. 2568.

Parameter Details
Audit Firm M/s. A.K. Verma & Co.
Designated Auditor Mr. Ashok Kumar Verma
Term Duration Five financial years (FY 2026-27 to FY 2030-31)
Predecessor Firm M/s. Deepak Bansal & Associates (Resigned)
Regulatory Basis Regulation 30 of SEBI LODR Regulations

AGM Proceedings and Governance

The 52nd AGM was conducted via Video Conferencing or Other Audio-Visual Means (OAVM) due to the absence of Anil Modi, who was unable to attend due to ill health. Akshay Modi chaired the meeting, which commenced at 2:30 p.m. IST and concluded at 3:13 p.m. IST. A total of 120 members joined the virtual session, with a quorum present throughout.

Remote e-voting was facilitated by Central Depository Services Limited (CDSL) from July 28, 2026, at 10:00 a.m. IST to July 30, 2026, at 5:00 p.m. IST. Out of 13,306,397 shares held by 7,224 shareholders on the record date of July 24, 2026, a total of 6,581,749 votes were polled. All six ordinary resolutions, including the adoption of FY26 financial statements and the re-appointment of Mrs. Aditi Modi as Director, passed with support exceeding 99.99%.

Promoter group shareholders cast 6,486,321 votes, representing 70.55% of outstanding shares, ensuring the passage of all agenda items. Public non-institutional shareholders contributed 95,428 votes, with over 99.98% voting in favor of each resolution. Rajan Kumar Singh, the Company Secretary and Compliance Officer, confirmed that reports from both the Statutory Auditors (M/s Doogar & Associates Chartered Accountants) and the outgoing Secretarial Auditor contained no qualifications or adverse remarks.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.22%+2.00%-13.38%+19.90%0.0%0.0%

How might the change in secretarial auditor impact Modi Naturals' compliance reporting timelines or regulatory risk profile during the transition period?

Given Anil Modi's absence due to ill health, what are the potential implications for the company's long-term leadership succession and strategic direction?

Will the unanimous approval of all resolutions, including the re-appointment of Mrs. Aditi Modi, signal a consolidation of promoter control that could affect minority shareholder interests?

Modi Naturals appoints Ankita Singal as independent director at subsidiary

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Modi Naturals Limited appointed Ankita Singal as an independent director at its subsidiary Modi Biotech Private Limited on July 30, 2026. The appointment follows approval at the subsidiary's AGM and complies with SEBI Listing Regulations. Singal brings two decades of experience in finance and business management to the board.

powered bylight_fuzz_icon
46973416

*this image is generated using AI for illustrative purposes only.

Modi Naturals Limited has appointed Ankita Singal as a Non-Executive Independent Women Director at its unlisted material subsidiary, Modi Biotech Private Limited. The appointment was approved by the members of Modi Biotech at their fifth Annual General Meeting held on July 30, 2026, and becomes effective on the same date. This move strengthens the governance framework of the subsidiary, ensuring compliance with regulatory requirements for independent representation on the board.

The disclosure was made in compliance with Regulation 24 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the company adhered to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, regarding disclosures related to changes in directorship. Rajan Kumar Singh, Company Secretary & Compliance Officer of Modi Naturals Limited, signed the intimation letter submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE).

Appointment Details

The key details of the appointment are outlined below:

Particulars Details
Appointee Ankita Singal (DIN: 01633449)
Role Non-Executive Independent Women Director
Entity Modi Biotech Private Limited
Effective Date July 30, 2026
Approval Forum 5th Annual General Meeting of Modi Biotech

Profile and Compliance

Ankita Singal holds a Bachelor of Commerce (Honours) degree from Lady Shriram College for Women, Delhi University, and a Master in Business Administration from Infinity Business School. She possesses approximately 20 years of experience across finance, marketing, and general business management.

As per the disclosure requirements under BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018, and NSE Circular No. NSE/CML/2018/02 dated June 20, 2018, Singal is not related to any existing directors of Modi Naturals Limited. Furthermore, she is not debarred from holding the office of a Director by virtue of any order issued by the Ministry of Corporate Affairs (MCA), SEBI, or any other statutory authority.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.22%+2.00%-13.38%+19.90%0.0%0.0%

How might Ankita Singal's 20 years of experience in finance and marketing influence Modi Biotech's strategic growth plans for its unlisted operations?

Does this appointment signal a broader initiative by Modi Naturals to enhance corporate governance across its subsidiary portfolio ahead of potential future listing requirements?

What specific regulatory or operational challenges within the biotech sector is Modi Biotech aiming to address by strengthening its independent board representation?

More News on Modi Naturals

1 Year Returns:0.00%